Skip to main content

Table 1 General clinical information in both groups

From: Midterm postoperative prognosis of patients with severe left heart valvular disease combined with moderate or severe pulmonary hypertension treated with treprostinil

Items

Group T (n = 21)

Group C (n = 40)

P-value

Age (year)

58.0 [53.0, 61.0]

59.0 [53.0, 64.3]

0.252

Gender (female/male)

13/8

25/15

0.964

Valvular surgery (single valve replacement/double valve replacement)

18/3

36/4

0.618

PASP (mmHg)

67.0 [63.0, 74.0]

65.5 [62.5, 71.3]

0.261

Ejection fraction (%)

61.3 [54.8, 66.3]

62.3 [55.4, 68.7]

0.872

LVEDD (mm)

56.3 [53.8, 59.1]

56.1 [49.1, 61.6]

0.723

HR (times)

81.0 [75.0, 87.0]

82.0 [76.0, 89.0]

0.542

mPAP (mmHg)

42.0 [38.0, 47.0]

43.0 [40.0, 46.3]

0.979

NYHA

4/13/4

6/27/7

0.895

6-MWD (m)

352 [312, 376]

336 [284, 375]

0.832

Borg score

5.00 [4.00, 5.00]

5.00 [4.00, 5.00]

0.891

CPB time (min)

82.0 [77.0, 115]

88.5 [78.8, 116]

0.802

Aortic cross-clamp time (min)

44.0 [37.0, 69.0]

44.5 [40.0, 69.3]

0.811

Surgery time

123 [101, 145]

133 [122, 145]

0.529